FDA proposes to exclude semaglutide, tirzepatide from compounding list
Go back to FDA proposes to exclude semaglutide, tirzepatide from compounding list| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1210.02 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1210.02 | 52 Week High | $88.16 | |||
| Open | $1210.02 | 52 Week Low | $67.88 | |||
| Day High | $1210.02 | P/E | 280.10 | |||
| Day Low | $1210.02 | EPS | $4.32 | |||
| Volume | 5,309 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 51.58 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $51.58 | 52 Week High | $59.00 | |||
| Open | $51.58 | 52 Week Low | $32.80 | |||
| Day High | $51.58 | P/E | N/A | |||
| Day Low | $51.58 | EPS | $0.00 | |||
| Volume | 96,263 | |||||

